Exchange Traded Concepts, LLC Innate Pharma Sa Transaction History
Exchange Traded Concepts, LLC
- $3.81 Billion
- Q1 2024
A detailed history of Exchange Traded Concepts, LLC transactions in Innate Pharma Sa stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 113,070 shares of IPHA stock, worth $232,924. This represents 0.01% of its overall portfolio holdings.
Number of Shares
113,070
Previous 46,888
141.15%
Holding current value
$232,924
Previous $131,000
148.09%
% of portfolio
0.01%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding IPHA
# of Institutions
10Shares Held
254KCall Options Held
0Put Options Held
0-
Optiver Holding B.V. Amsterdam, P770.6KShares$145,3610.01% of portfolio
-
Morgan Stanley New York, NY44.1KShares$90,8950.0% of portfolio
-
Jane Street Group, LLC New York, NY14.6KShares$29,9810.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny10.6KShares$21,7920.0% of portfolio
-
Barclays PLC London, X0412Shares$8480.0% of portfolio
About Innate Pharma SA
- Ticker IPHA
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,893,000
- Market Cap $165M
- Description
- Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and periphera...